Gut Microbiota as a Biomarker of Hepatocellular Carcinoma in Patients With Cirrhosis

被引：0
|
作者：
Nobel, Yael R. [1 ]
Park, Heekuk [1 ]
Koerner, Anna [1 ]
Tillman, Alice M. [1 ]
Seeram, Dwayne [1 ]
Moallem, Dalia H. [1 ]
Annavajhala, Medini K. [1 ]
Gomez-Simmonds, Angela [1 ]
Verna, Elizabeth C. [1 ]
Uhlemann, Anne-Catrin [1 ]
机构：
[1] Columbia Univ, Irving Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1499
引用
收藏
页码：S1136 / S1137
页数：2
相关论文
共 50 条
  • [1] Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
    Zheng, Ruipeng
    Wang, Guoqiang
    Pang, Zhiqiang
    Ran, Nan
    Gu, Yinuo
    Guan, Xuewa
    Yuan, Yuze
    Zuo, Xu
    Pan, He
    Zheng, Jingtong
    Wang, Fang
    CANCER MEDICINE, 2020, 9 (12): : 4232 - 4250
  • [2] Gut microbiota and hepatocellular carcinoma
    Wang, Panzhi
    Chen, Kun
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (03) : 345 - 347
  • [3] Gut Microbiota and Hepatocellular Carcinoma
    Tao, Xuemei
    Wang, Ning
    Qin, Wenxin
    GASTROINTESTINAL TUMORS, 2015, 2 (01) : 33 - 40
  • [4] The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma
    Zamparelli, Marco Sanduzzi
    Rocco, Alba
    Compare, Debora
    Nardone, Gerardo
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (07) : 944 - 953
  • [5] Alteration of gut microbiota in patients with advanced hepatocellular carcinoma.
    Charoenthanadhol, Thanakorn
    Wirasorn, Kosin
    Sookprasert, Aumkhae
    Chindaprasert, Jarin
    Sanlung, Thanachai
    Watcharenwong, Piyakarn
    Putraveephong, Siraphong
    Phetcharaburanin, Jutarop
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 641 - 641
  • [6] Inflammatory and carcinogenic features of gut microbiota in hepatocellular carcinoma patients
    Iida, Noriho
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    HEPATOLOGY, 2016, 64 : 84A - 84A
  • [7] Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis
    Grat, M.
    Wronka, K. M.
    Krasnodebski, M.
    Masior, K.
    Lewandowski, Z.
    Kosinska, I.
    Grat, K.
    Stypulkowski, J.
    Rejowski, S.
    Wasilewicz, M.
    Galecka, M.
    Szachta, P.
    Krawczyk, M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (05) : 1687 - 1691
  • [8] Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery
    Di Poto, Cristina
    Ferrarini, Alessia
    Zhao, Yi
    Varghese, Rency S.
    Tu, Chao
    Zuo, Yiming
    Wang, Minkun
    Ranjbar, Mohammad R. Nezami
    Luo, Yue
    Zhang, Chi
    Desai, Chirag S.
    Shetty, Kirti
    Tadesse, Mahlet G.
    Ressom, Habtom W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05) : 675 - 683
  • [9] Gut Microbiota as Biosensors in Patients With Cirrhosis
    Bajaj, Jasmohan S.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2019, 8 (02): : 231 - 233
  • [10] Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
    Wang, Yiqin
    Li, Yongqiang
    Lin, Yong
    Cao, Chuangyu
    Chen, Dongcheng
    Huang, Xianguang
    Li, Canhua
    Xu, Haoming
    Lai, Huasheng
    Chen, Huiting
    Zhou, Yongjian
    CELL DEATH DISCOVERY, 2025, 11 (01)
12345